5 Things You Need to Know Before Enrolling in a Psilocybin Clinical Trial

October 7, 2020 13:00:29

Psychedelics have generated a lot of interest of late and a number of clinical trials are planned or are already underway to deepen our understanding of these substances and what they can or cannot do. If you are considering to enroll for a psilocybin clinical trial near you, here are five important things you need to keep in mind.

Where to Find Psilocybin Clinical Trials

By law, every clinical trial that is scheduled to take place within the borders of the U.S. has to register at ClinicalTrials.gov. This site will give you a summary of the substance or device being tested, the trial locations, eligibility criteria and contact information for the people in charge of that clinical trial. Read those summaries and see if anything interests you.

Are You Eligible to Participate in the Clinical Trial?

The summary provided on the site above includes a detailed description of the inclusion as well as exclusion criteria for the people wishing to enroll for that particular psilocybin clinical trial. The inclusion criteria could include details about the medical condition, such as moderate depression, which the researchers would like to study, as well as the age bracket of desirable study subjects, and other relevant information.

The exclusion criteria refers to the conditions intending participants shouldn’t have since those conditions may put them at a higher risk of adverse events or may compromise the effectiveness of the substance under investigation. For example, the clinical trial summary could exclude pregnant or breastfeeding mothers, or individuals who are currently taking certain medications.

When you read the eligibility criteria, you will have a clear idea about whether you qualify to enroll or not.

Who is the Sponsor of the Psilocybin Clinical Trial?

It is also important for you to find out who is sponsoring that particular psilocybin clinical trial that you wish to enroll into. Clinical trials are either conducted to increase the available knowledge about a substance or medication, or they are intended to meet the regulatory requirements for a remedy to be approved for use.

Knowing who the sponsor is can help you to decide whether the intentions of that entity align with your own beliefs and values.

What to Expect Once You Enroll as a Clinical Trial Participant

Each clinical trial may have its own unique design requirements. For example, one psilocybin trial may require you to stay overnight at the clinical trial site several times each week while another may require you to spend just an hour or so each week. It is important that you understand those requirements so that you know what you are getting into.

Additionally, many clinical trials are blinded studies. This means that study subjects will be divided into two random groups, one of which will receive a placebo while the other will receive the psilocybin treatment. You have no say in determining to which group you will be assigned, so if landing in the placebo group will be such a disappointment for you, then you could consider not enrolling.

How Do You Expect to Benefit by Enrolling for the Clinical Trial?

No clinical trial will guarantee any benefits to the people who participate in the study. However, some will provide some form of compensation to the participants for their time. There is no assurance that those who get the psilocybin will benefit from it, and there is a chance that you could receive a placebo. It is therefore advisable for you to manage your expectations regarding how you stand to benefit. What you can be sure of is that your participation will help a lot of people once the medication is proved to be helpful and safe.

As you can see, a lot of thought and research has to go into the decision to enroll for a psilocybin clinical trial, or any other trial for that matter. No wonder entities like Pure Extract Technologies Inc. recommend being informed before you make any decision!

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.